e-learning
resources
ERJ
2011
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Time interval to conversion of interferon-? release assay after exposure to tuberculosis
Lee S.W., Oh D.K., Lee S.H., Kang H.Y., Lee C-T., Yim J-J.
Source:
Eur Respir J 2011; 37: 1447-1452
Journal Issue:
June
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Lee S.W., Oh D.K., Lee S.H., Kang H.Y., Lee C-T., Yim J-J.. Time interval to conversion of interferon-? release assay after exposure to tuberculosis. Eur Respir J 2011; 37: 1447-1452
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Cost-effectiveness of interferon-γ release assay testing for the treatment of latent tuberculosis
Source: Eur Respir J 2007; 30: 321-332
Year: 2007
Quantitative scoring of an interferon-γ assay for differentiating active from latent tuberculosis
Source: Eur Respir J 2007; 30: 722-728
Year: 2007
Direct costs of three models for the screening of latent tuberculosis infection
Source: Eur Respir J 2006; 28: 45-50
Year: 2006
Avoiding the effect of BCG vaccination in detecting Mycobacterium tuberculosis infection with a blood test
Source: Eur Respir J 2006; 28: 16-23
Year: 2006
Interferon-gamma release assays in tuberculosis contacts: is there a window period?
Source: Eur Respir J 2011; 37: 215-217
Year: 2011
Can we predict who will develop TB among those with a positive interferon-? release assay (IGRA)?
Source: International Congress 2018 – Important changes in the management of tuberculosis
Year: 2018
Interferon-? release assays for the diagnosis of latent Mycobacterium tuberculosis infection
Source: Eur Respir J 2011; 38: 1238-1239
Year: 2011
What is the best test to detect latent tuberculosis infection in sarcoidosis patients? – Comparison between two commercially available interferon gamma release assays
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013
TB as an occupational disease
Source: Eur Respir Mon 2012; 58: 219-229
Year: 2012
Serial interferon-gamma release assays for screening and monitoring of tuberculosis infection during treatment with biologic agents
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Year: 2013
Tuberculin skin test or interferon gamma release assay - How to detect latent tuberculosis infection in sarcoidosis patients?
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015
Additional analysis of antigen-specific Interleukin-2 release does not improve the performance of IGRAs for the differentiation of different states of
mycobacterium tuberculosis
infection
Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection
Year: 2014
Serial interferon-gamma release assay in children with tuberculosis infection
Source: Annual Congress 2010 - Tuberculosis in children
Year: 2010
Interferon-gamma release assays (IGRA) for latent tuberculosis infection (LTBI) in children
Source: Annual Congress 2011 - Tuberculosis in pregnancy and childhood
Year: 2011
Use of a T-cell-based test for detection of tuberculosis infection among immunocompromised patients
Source: Eur Respir J 2006; 28: 31-34
Year: 2006
Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection
Source: Eur Respir J 2010; 35: 619-626
Year: 2010
LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement
Source: Eur Respir J 2009; 33: 956-973
Year: 2009
A combinatorial dual-immunoassay predicts reactivation risk for patients with previously incomplete treatment for latent tuberculosis infection
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016
Omics and single molecule detection: the future of TB diagnostics
Source: Eur Respir Mon 2012; 58: 144-153
Year: 2012
Impact of interferon-? release assay on the latent tuberculosis cascade of care: a population-based study
Source: Eur Respir J , 49 (3) 1601546; DOI: 10.1183/13993003.01546-2016
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept